Roche immunoassay cerebrospinal fluid phosphorylated tao protein (181P) test reagent - Taiwan Registration a19b49bf8967f1e9a1e32f8f93e29972
Access comprehensive regulatory information for Roche immunoassay cerebrospinal fluid phosphorylated tao protein (181P) test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number a19b49bf8967f1e9a1e32f8f93e29972 and manufactured by ROCHE DIAGNOSTICS GMBH. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
ๆฌ็ขๅๅฉ็จ้ปๅๅญธ็ผๅ ๅ ็ซๅๆๆณ(ECLIA),้ซๅคๅฎ้ๆชขๆธฌไบบ้ก่ ฆ่้ซๆถฒไธญ็็ฃท้ ธๅๆฟค่็ฝ(phosphorylated Tau Protein) ๆฟๅบฆ.
A Clinical Chemistry and Clinical Toxicology;; C Immunology and Microbiology
A.1660 Quality control materials (analytical and non-analytical); A.1150 calibration;; C.9999 Miscellaneous
Input;; QMS/QSD
Dates and Status
Feb 23, 2024
Feb 23, 2029

